Helicobacter pylori infection as a risk factor for insulin resistance

Digestive Diseases and Sciences

Volumn 54, Issue 9, 2009, Pages 1966-1970

  Eshraghian, Ahad ^a,b   Hashemi, Seyed Ali ^a   Jahromi, Alireza Hamidian ^c   Eshraghian, Hamed ^b   Masoompour, Seyed Masoum ^d   Davarpanah, Mohamad Ali ^d   Eshraghian, Kavus ^a   Taghavi, Seyed Alireza ^b  

^a JAHROM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fasting serum insulin; Helicobacter pylori; HOMA IR; Insulin resistance

Indexed keywords

INSULIN; BACTERIUM ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HELICOBACTER INFECTION; HUMAN; INFECTION RISK; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; SEROLOGY; ADOLESCENT; ADULT; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; HELICOBACTER PYLORI; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 68249160053     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0557-7     Document Type: Article

References (37)

1. DR Cave 1996 Transmission and epidemiology of Helicobacter pylori Am J Med 100 12 17 10.1016/S0002-9343(96)90004-2 (Pubitemid 26049319)
2. FA Wyle 1991 Helicobacter pylori: current perspectives J Clin Gastroenterol 13 114 124 10.1097/00004836-199112001-00020
3. P Ernst 1999 The role of inflammation in the pathogenesis of gastric cancer Aliment Pharmacol Ther 13 13 18 10.1046/j.1365-2036.1999.00003.x
4. JJ Misiewicz 1995 Current insights in the pathogenesis of Helicobacter pylori infection Eur J Gastroenterol Hepatol 7 701 703
5. R Pellicano S Fagoonee M Rizzetto A Ponzetto 2003 Helicobacter pylori and coronary heart disease: which directions for future studies? Crit Rev Microbiol 29 351 359
6. AR Salteil CR Kahn 2001 Insulin signalling and the regulation of glucose and lipid metabolism Nature 414 799 10.1038/414799a (Pubitemid 34000783)
7. DE Moller J Flier 1991 Insulin resistance mechanisms, syndromes and implications N Engl J Med 325 938 948
8. JA Beckman 2002 Diabetes and atherosclerosis: epidemiology, pathophysiology, and management JAMA 287 2570 10.1001/jama.287.19.2570
9. SM Haffner H Miettinen 1997 Insulin resistance implications for type II diabetes mellitus and coronary heart disease Am J Med 103 152 162 10.1016/S0002-9343(97)00027-2 (Pubitemid 27352120)
10. JB Ruige WJ Assendelft JM Dekker PJ Kostense RJ Heine LM Bouter 1998 Insulin and risk of cardiovascular disease: a meta-analysis Circulation 97 996 1001
11. K Shinohara T Shoji M Emoto H Tahara H Koyama E Ishimura T Miki T Tabata Y Nishizawa 2002 Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease J Am Soc Nephrol 13 1894 1900 10.1097/01.ASN.0000019900.87535.43 (Pubitemid 34700615)
12. SF Moss S Legon AE Bishop JM Polak J Calam 1992 Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease Lancet 340 930 932 10.1016/0140-6736(92)92816-X
13. S Aydemir T Bayraktaroglu M Sert C Sokmen H Atmaca G Mungan BD Gun A Borazan Y Ustundag 2005 The effect of Helicobacter pylori on insulin resistance Dig Dis Sci 50 2090 2093 10.1007/s10620-005-3012-z (Pubitemid 41504094)
14. TM Wallace JC Levy DR Matthews 2004 Use and abuse of HOMA modeling Diabetes Care 27 1487 1495 10.2337/diacare.27.6.1487 (Pubitemid 38680001)
15. E Bonora G Targher M Alberiche RC Bonadonna F Saggiani MB Zenere T Monauni M Muggeo 2000 Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity Diabetes Care 23 57 63 10.2337/diacare.23.1.57
16. E Ferrannini 1998 Insulin resistance vs insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects Endocr Rev 19 477 490 10.1210/er.19.4.477
17. M Kasuga 2006 Insulin resistance and pancreatic β cell failure J Clin Invest 116 1756 1760 10.1172/JCI29189 (Pubitemid 44033294)
18. JM Fernández-Real JC Pickup 2008 Innate immunity, insulin resistance and type 2 diabetes Trends Endocrinol Metab 19 10 16 10.1016/j.tem.2007.10.004
19. MA Lazar 2005 How obesity causes diabetes: not a tall tale Science 307 373 375 10.1126/science.1104342 (Pubitemid 40139971)
20. JM Mooy H de Vries PA Grootenhuis LM Bouter RJ Heine 2000 Major stressful life events in relation to prevalence of undetected type 2 diabetes: the Hoorn Study Diabetes Care 23 197 201 10.2337/diacare.23.2.197
21. CG Foy RA Bell DF Farmer DC Goff Jr LE Wagenknecht 2005 Smoking and incidence of diabetes among U.S. adults: findings from the Insulin Resistance Atherosclerosis Study Diabetes Care 28 2501 2507 10.2337/diacare.28.10.2501 (Pubitemid 41384301)
22. JM Fernández-Real MJ Ferri J Vendrell W Ricart 2007 Burden of infection and fat mass in healthy middle-aged men Obesity (Silver Spring) 15 245 252 10.1038/oby.2007.541
23. JM Fernández-Real A López-Bermejo J Vendrell MJ Ferri M Recasens W Ricart 2006 Burden of infection and insulin resistance in healthy middle-aged men Diabetes Care 29 1058 1064 10.2337/dc05-2068
24. H Kaneko T Konagaya K Kusugami 2002 Helicobacter pylori and gut hormones J Gastroenterol 37 77 86 10.1007/s005350200000 (Pubitemid 34223739)
25. JF Rehfeld F Stadil 1973 The effect of gastrin on basal- and glucose stimulated insulin secretion in man J Clin Invest 52 1415 1426 10.1172/JCI107315
26. TJ Colturi RH Unger M Feldman 1984 Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients J Clin Invest 74 417 423 10.1172/JCI111437
27. P Wiesli W Czerwenka A Meniconi FE Maly U Hoffmann W Vetter G Schulthess 2002 Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial Circulation 105 2646 2652 10.1161/01.CIR.0000017862.08503.15 (Pubitemid 34596042)
28. BJ Wells AG Mainous LM Dickerson 2004 Antibiotics for the secondary prevention of ischemic heart disease: a meta-analysis of randomized controlled trials Arch Intern Med 164 2156 2161 10.1001/archinte.164.19.2156 (Pubitemid 39410806)
29. JT Grayston RA Kronmal LA Jackson AF Parisi JB Muhlestein JD Cohen WJ Rogers JR Crouse SL Borrowdale E Schron C Knirsch ACES Investigators 2005 Azithromycin for the secondary prevention of coronary events N Engl J Med 352 1637 1645 10.1056/NEJMoa043526 (Pubitemid 40530230)
30. B Cohen D Novick M Rubinstein 1996 Modulation of insulin activities by leptin Science 274 1185 1188 10.1126/science.274.5290.1185 (Pubitemid 26389283)
31. N Salles A Ménard A Georges M Salzmann V de Ledinghen A de Mascarel JP Emeriau H Lamouliatte F Mégraud 2006 Effects of Helicobacter pylori infection on gut appetite peptide (leptin, ghrelin) expression in elderly inpatients J Gerontol A Biol Sci Med Sci 61 1144 1150
32. KB Lankarani M Moghadami M Masoumpoor B Geramizadeh GR Omrani 2004 Serum leptin level in patients with functional dyspepsia Dig Liver Dis 36 717 721 10.1016/j.dld.2004.07.001 (Pubitemid 41070592)
33. Y Nishi H Isomoto S Uotani CY Wen S Shikuwa K Ohnita Y Mizuta A Kawaguchi K Inoue S Kohno 2005 Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection World J Gastroenterol 7 695 699
34. RF Gillum 2004 Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey J Natl Med Assoc 96 1470 1476
35. SH Park WK Jeon SH Kim HJ Kim DI Park YK Cho IK Sung CI Sohn BI Kim DK Keum 2005 Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters J Natl Med Assoc 97 508 513
36. S Ozdem M Akcam A Yilmaz R Artan 2007 Insulin resistance in children with Helicobacter pylori infection J Endocrinol Invest 30 36 40
37. B Longo-Mbenza J Nkondi Nsenga D Vangu Ngoma 2007 Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics Int J Cardiol 121 229 238 10.1016/j.ijcard.2006.12.003 (Pubitemid 47469953)